Shukra Pharmaceuticals Shareholding

Shukra Pharmaceuticals Ltd Shareholding Pattern

The Shukra Pharmaceuticals Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Shukra Pharmaceuticals Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Shukra Pharmaceuticals Ltd (NSE: , BSE: 524632) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Shukra Pharmaceuticals Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Shukra Pharmaceuticals Ltd Shareholding Pattern (Latest)

The latest Shukra Pharmaceuticals Ltd shareholding for Mar 2026 is:

• Promoters: 50.96%
• FII: 0%
• DII: 0.11%
• Public: 48.93%
• Government: 0%

Promoter holding in Shukra Pharmaceuticals Ltd remains stable, reflecting consistent long-term commitment.

Shukra Pharmaceuticals Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Shukra Pharmaceuticals Ltd.

• Mar 2026: 50.96%
• Dec 2025: 50.96%
• Sept 2025: 50.96%
• Jun 2025: 50.96%
• Mar 2025: 50.96%

Promoter stake remains largely stable, showing consistent ownership structure.

Shukra Pharmaceuticals Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Shukra Pharmaceuticals Ltd.

• Mar 2026: 0%
• Dec 2025: 0%
• Sept 2025: 0%
• Jun 2025: 0%
• Mar 2025: 0%

FII holding has declined, suggesting cautious sentiment among foreign investors.

Shukra Pharmaceuticals Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Mar 2026: 0.11%
• Dec 2025: 0.11%
• Sept 2025: 0.11%
• Jun 2025: 0.11%
• Mar 2025: 0.11%

DII holdings remain stable, reflecting steady institutional participation.

Shukra Pharmaceuticals Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Mar 2026: 48.93%
• Dec 2025: 48.93%
• Sept 2025: 48.93%
• Jun 2025: 48.93%
• Mar 2025: 48.93%

Public holding remains stable with consistent retail participation.

Shukra Pharmaceuticals Ltd Government Holding

Government holding in Shukra Pharmaceuticals Ltd currently stands at 0%.

Shukra Pharmaceuticals Ltd operates without significant government ownership.

Shukra Pharmaceuticals Ltd Shareholding Analysis Summary

The Shukra Pharmaceuticals Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Shukra Pharmaceuticals Ltd shows strong promoter and domestic institutional confidence, which is positive for long-term investors.

Regular monitoring of the Shukra Pharmaceuticals Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.